1
项与 Anti-cd7 CARNK cell therapy (PersonGen Biomedicine) 相关的临床试验Chimeric Antigen Receptor-Modified pNK Cells for CD7 Positive Relapsed or Refractory Leukemia and Lymphoma
The purpose of this study is to evaluate the safety and effectiveness of CAR-pNK cell immunotherapy in patients with CD7 positive relapsed or refractory Leukemia and Lymphoma.
100 项与 Anti-cd7 CARNK cell therapy (PersonGen Biomedicine) 相关的临床结果
100 项与 Anti-cd7 CARNK cell therapy (PersonGen Biomedicine) 相关的转化医学
100 项与 Anti-cd7 CARNK cell therapy (PersonGen Biomedicine) 相关的专利(医药)
100 项与 Anti-cd7 CARNK cell therapy (PersonGen Biomedicine) 相关的药物交易